FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Gabapentin submitted by Amneal Pharmaceuticals LLC under ANDA202024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neuropathic Pain
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)